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doi:10.1016/j.ejvsextra.2009.12.001Abstract Endovascular aneurysm repair (EVAR) is increasingly used to treat infrarenal
abdominal aortic aneurysm. EVAR is almost exclusively accomplished by using bifurcated, bi-
iliac stentgrafts. Nevertheless, it is accompanied with a considerable incidence of stentgraft
limb occlusion. In case of acute occlusion endovascular revascularization options are plentiful,
but for chronically occluded stentgraft limbs such consensus is lacking. Catheter-delivered
transducer-tipped ultrasound (US) thrombolysis is a new technique specifically coined for
the treatment of (sub)acute peripheral arterial occlusions and deep venous thrombosis. We
describe a unique case of successful treatment of a chronically occluded stentgraft limb after
EVAR with catheter-delivered transducer-tipped US thrombolysis.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license .Introduction
Endovascular aneurysm repair is rapidly becoming the
standard treatment for infrarenal abdominal aortic aneu-
rysm (AAA). Follow-up studies are recommended however,
since there are a substantial number of graft-related
complications. One of such adverse events, graft limb
occlusion, has been reported to occur in 3.1e7.2% ofjvs.2009.12.032.
444517; fax: þ31204443620.
c.nl (A.W.J. Hoksbergen).
r Vascular Surgery. Published bypatients, mostly within one year after EVAR.1 Endovascular
revision, consisting of catheter-directed thrombolysis or
thrombosuction in combination with percutaneous trans-
luminal angioplasty (PTA) with or without stent placement,
has become the preferred treatment in case of acute
arterial occlusions.2 If the time of onset is unknown or the
occlusion has existed for more than 14 days surgical
thrombectomy and/or revision has been recommended.2 If
attempted, standard thrombolysis in case of chronic
occlusion most likely will require several days of infusion of
the thrombolytic agent at high dosage. This treatment
carries a significant risk of bleeding complications and
probability of incomplete thrombolysis. Catheter-deliveredElsevier Ltd.Open access under CC BY-NC-ND license .
Figure 1 CT-angiography demonstrating occlusion of the left
limb of the aortic stentgraft.
Figure 2 Completion angiography after US enhanced
thrombolysis and PTA demonstrating no residual thrombosis or
stenosis.
e26 L. Daniels et al.transducer-tipped ultrasound (US) thrombolysis is a new
technique that adds a mechanical component to chemical
thrombolysis and therefore conceivably could fragment and
lyse older thrombi. We present a unique case of a patient
with a chronically occluded stentgraft limb after EVAR who
was successfully treated by a combination of thrombolysis
and US.
Case report
A 55-year old male with a medical history of myocardial
infarction, hypertension and coronary artery bypass graft-
ing, underwent an uncomplicated EVAR procedure (Cook,
Zenith) for an asymptomatic infrarenal AAA of 5.6 cm. The
stentgraft limbs were placed in non-stenotic common iliac
arteries and there was no peripheral arterial occlusive
disease. Seven months after EVAR the patient complained of
pain in his left foot during walking. Physical examination did
not show signs of leg ischemia and all peripheral arterial
pulsations were palpable. Furthermore, preoperative CT-
scanning and routine postoperative CT-scanning 4 weeks
after EVAR had not shown any signs of central or peripheral
arterial occlusive disease and therefore a vascular cause of
the complaints was not suspected. A neurological cause of
the pain was excluded as well. Nine months after EVAR the
pain had suddenly worsened and now involved the whole leg
and the painfree walking distance had fallen to 50 m.
However, the patient sought medical attention for this new
problem only after another 4 months. Physical examination
now revealed absence of arterial pulsations of the left leg.
Contrast enhanced CT-scanning showed occlusion of the left
limb of the aortic stentgraft (Fig. 1) without signs of
migration or kinking. In light of the chronic nature (>4
months) of the occlusion, reopening of the stentgraft limb
with standard catheter-directed thrombolysis was not
considered a realistic option. Therefore US enhanced
thrombolysis was performed. After retrograde access was
gained, recanalization of the left thrombosed stentgraft
limb was performed with a 0.035-inch angled guidewire
(Terumo, Leuven, Belgium) and a 5 Fr. PIER catheter(Cordis, Miami Lakes, FL, USA) and a 5 Fr. C2 Cobra catheter
(COOK, Bloomington, IN, USA). Then a 12 cm EKOS drug
delivery catheter with a multi-transducer US core wire was
inserted in the thrombus (EKOS Corporation, Bothell, WA,
USA). A 500,000 IE urokinase bolus was administered fol-
lowed by a continuous infusion of 100,000 IE/h combined
with 2.1 MHz US. Four hours after initiation of treatment
partial dissolution of the thrombus was seen on angiography.
After another 16 h, angiography showed complete dissolu-
tion of the thrombus. Three significant stenotic lesions in
the affected stentgraft limb remained, which were all
treated by PTA with 12.0 40 mm Smash balloons (Boston
Scientific, Galway, Ireland). The most proximal stenosis was
treated with a kissing balloon technique. The stenoses might
have been caused by stentgraft folding due to oversizing, or
they might be residual thrombus. Kinking of the stentgraft
limb was not found and there were no stenotic lesions in the
iliac artery. Completion angiography demonstrated no
residual thrombosis or stenosis and therefore no additional
stents were inserted (Fig. 2). Total urokinase infusion time
was 20 h and 34 min. Antiplatelet therapy was continued
and during follow-up the symptoms had disappeared.
Discussion
Treatment of chronic native arterial or graft occlusions with
thrombolysis is questionable. Catheter-directed thrombol-
ysis for chronic limb ischemia has a lower success rate and
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Incomplete thrombolysis, as well as a high bleeding rate,
related to overall dose of the thrombolytic agent and
duration of therapy, stimulated research on alternative
therapies. The use of US energy to enhance thrombolysis
dates back to 1976.4 The exposure to US causes reversible
disaggregation of uncrosslinked fibrin bundles into smaller
fibres and microcavity formation in the thrombus. This
increases penetration of fibrinolytic drugs into the clot and
creates additional binding sites for fibrinolytic components,
which in turn leads to residual flow enhancement with
microstreaming and vessel dilation as well as improvement
of fibrinolytic efficacy.5 US energy can be applied by
a transcutaneous approach, however catheter-delivered
transducer-tipped US thrombolysis is a more innovative
method. A number of studies have been published on the
effects of transducer-tipped US combined with thrombol-
ysis for lower limb ischemia, deep venous thrombosis and
stroke. A reduction of total infusion time of the thrombo-
lytic agent, a greater incidence of complete lysis and
a reduction in bleeding rates compared with conventional
thrombolysis have been demonstrated.4
We showed that even in the case of chronic occlusion of
a stentgraft limb after EVAR, rapid dissolution andreopening of the graft can be achieved with the use of US
enhanced thrombolysis.
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